Emerging US Diagnostic Testing Market Report 2016: Segment Forecasts and Supplier Shares by Test

DUBLIN, Oct. 20, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/92tk62/2016_emerging_us) has announced the addition of the "2016 Emerging US Diagnostic Testing Market: Segment Forecasts and Supplier Shares by Test" report to their offering.

This new report provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:

- Blood Banking
- Cancer
- Chemistry
- Coagulation
- Drugs of Abuse
- Endocrine
- Hematology and Flow Cytometry
- Immunoprotein
- Infectious Diseases
- Molecular Diagnostics
- TDM

Companies Mentioned

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako

For more information visit http://www.researchandmarkets.com/research/92tk62/2016_emerging_us

Media Contact:Laura Wood , [phone], [e-mail]